CompletedNCT03646981

Evaluation of Antibody Detection Tests for Visceral Leishmaniasis Diagnosis in Eastern Africa

Studying Leishmaniasis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Foundation for Innovative New Diagnostics, Switzerland
Principal Investigator
Israel Cruz, PhD
Find
Intervention
Leishmania Ab Rapid Test (CTK, Biotech)(device)
Enrollment
704 enrolled
Eligibility
4-100 years · All sexes
Timeline
2019 – 2021

Study locations (2)

Collaborators

University of Gondar · Kenya Medical Research Institute · London School of Hygiene and Tropical Medicine · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Drugs for Neglected Diseases

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03646981 on ClinicalTrials.gov

Other trials for Leishmaniasis

Additional recruiting or active studies for the same condition.

See all trials for Leishmaniasis →

← Back to all trials